March 20 (Reuters) - Arovella Therapeutics Ltd (ALA) :
- ALA-101 AND ONCARLYTICS COLLABORATION UPDATE
- IMUGENE HAS ADVISED AROVELLA THAT IT NO LONGER WISHES TO CONTINUE COLLABORATION
- PARTNERSHIP TO COMBINE ALA‐101 AND ONCARLYTICS HAS ENDED
- NO FINANCIAL IMPACT FROM CESSATION OF COLLABORATION FOR AROVELLA
- COLLABORATION WILL BE TERMINATED WITH IMMEDIATE EFFECT
- TERMINATION WILL NOT IMPACT CO'S DEVELOPMENT OF ALA‐101 FOR CD19‐POSITIVE BLOOD CANCERS
(([email protected];;))
- Forums
- ASX - By Stock
- ALA
- News: ALA Arovella Therapeutics Gives ALA-101 And Oncarlytics Collaboration Update
ALA
arovella therapeutics limited
Add to My Watchlist
3.75%
!
8.3¢

News: ALA Arovella Therapeutics Gives ALA-101 And Oncarlytics Collaboration Update
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
8.3¢ |
Change
0.003(3.75%) |
Mkt cap ! $99.27M |
Open | High | Low | Value | Volume |
8.1¢ | 8.4¢ | 8.1¢ | $56.30K | 680.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 236650 | 8.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.5¢ | 187486 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 236650 | 0.082 |
2 | 66785 | 0.081 |
3 | 157986 | 0.080 |
5 | 146825 | 0.079 |
4 | 378960 | 0.078 |
Price($) | Vol. | No. |
---|---|---|
0.085 | 176126 | 4 |
0.086 | 96430 | 2 |
0.087 | 122211 | 1 |
0.089 | 301136 | 2 |
0.090 | 15500 | 1 |
Last trade - 11.29am 16/09/2025 (20 minute delay) ? |
Featured News
ALA (ASX) Chart |
The Watchlist
FBM
FUTURE BATTERY MINERALS LIMITED
Nick Rathjen, MD & CEO
Nick Rathjen
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online